KC
AKCA

Kellner Capital’s Akcea Therapeutics Inc AKCA Stock Holding History

Kellner Capital’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-194,100
Closed -$3.52M – 42
2020
Q3 		$3.52M Buy
+194,100
New +$2.75M 1.91% 15

Kellner Capital's AKCA Position: Q4 2020 in Review

Kellner Capital sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 194,100 shares — an estimated $3.52M sold.

Kellner Capital first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $3.52M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Kellner Capital reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Kellner Capital sold 194,100 Akcea Therapeutics Inc shares in Q4 2020, an estimated $3.52M.
  • Kellner Capital first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
  • Kellner Capital's Akcea Therapeutics Inc position peaked at $3.52M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Kellner Capital's 13F filing for Q4 2020, filed 10 Feb 2021.